Clinical Trial Update: Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes the use of Ablatherm Integrated Imaging High Intensity Focused Ultrasound for low-risk, localized prostate cancer evaluated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ablatherm Integrated Imaging High Intensity Focused Ultrasound

Snippet

Sponsor: EDAP TMS S.A. | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: UNKNOWN